Glucophage/Glucophage Forte/Glucophage XR

Glucophage/Glucophage Forte/Glucophage XR

metformin

Manufacturer:

Merck

Distributor:

Zuellig
Concise Prescribing Info
Contents
Metformin HCl
Indications/Uses
Type 2 DM: Monotherapy or in combination w/ other oral antidiabetics. 1st line therapy in overwt type 2 diabetic adult patients. Prevention of type 2 DM in patients w/ prediabetes & at least 1 additional risk factor in whom lifestyle modifications alone have not reached adequate glycemic control. Glucophage/Glucophage Forte Type 2 DM in childn ≥10 yr & adolescents.
Dosage/Direction for Use
Glucophage/Glucophage Forte Adult Monotherapy or in combination w/ other oral antidiabetic agents Initially 500 mg or 850 mg bid-tid. Max of 3 g daily as 3 divided doses. Monotherapy in prediabetes 1,000-1,700 mg/day divided in 2 doses given. Combination w/ insulin Initially 500 mg or 850 mg bid or tid, while insulin dosage is adjusted on the basis of blood glucose measurements. Childn 10 yr & adolescents Monotherapy or in combination w/ insulin 500 or 850 mg once daily. Max of 2 g daily as 2 or 3 divided doses. Glucophage XR Monotherapy & combination w/ oral antidiabetic agents Initially 500 or 750 mg once daily w/ the evening meal. May increase to 1 g as maintenance therapy for patients already treated w/ metformin. Dose adjustment based on blood glucose measurements is recommended after 10-15 days. A slow increase of dose may improve GI tolerability. Max recommended dose for 500 mg tab: 4 tab daily. Recommended dose of 750 mg tab: 2 tab once daily. If glycemic control is still not achieved on 2 tab of 750 mg once daily, may be increased to a max dose of 3 tab daily. Max recommended dose of 1 g: 2 tab daily. Combination w/ insulin Initially 500 mg or 750 mg once daily, while insulin dosage is adjusted on the basis of blood glucose measurements. Monotherapy for prediabetes 1,000-1,500 mg once daily. Moderate renal impairment stage 3 CrCl 30-59 mL/min or eGFR 30-59 mL/min/1.73 m2 Starting dose: 500 mg or 850 mg daily. Max: 1,000 mg.
Administration
Should be taken with food: XR tab: Swallow whole, do not chew/crush. Must be taken daily w/o interruption w/ evening meal.
Contraindications
Hypersensitivity; any type of metabolic acidosis (eg, lactic acidosis, diabetic ketoacidosis; diabetic pre-coma; severe renal failure (CrCl <30 mL/min) or eGFR <30 mL/min/1.73 m2); acute conditions w/ the potential to alter renal function eg, dehydration, severe infection or shock, iodinated contrast materials in radiodiagnostic exam can lead to renal failure. Elective major surgery; acute or chronic disease which may cause tissue hypoxia eg, unstable CHF, resp failure, recent MI or shock, hepatic insufficiency acute alcohol intoxication, alcoholism.
Special Precautions
Conditions where renal function may be acutely impaired eg, elderly, when initiating antihypertensive or diuretic therapy & when starting therapy w/ NSAID. Risk of lactic acidosis. Patient should continue following dietary advice. Avoid consumption of alcoholic beverages. Possible hypoglycemia when in combination w/ insulin or sulfonylureas. Regularly perform lab tests for diabetes. Patients w/ serum levels at the upper limit of normal. May affect ability to drive or operate machinery on the onset of hypoglycemia. Pregnancy. Not recommended during lactation. Glucophage/Glucophage Forte Childn.
Adverse Reactions
GI disorders eg, nausea, vomiting, diarrhea, abdominal pain & loss of appetite; taste disturbance.
Drug Interactions
Patients w/ CrCl <45 mL/min or eGFR <45 mL/min/1.73 m2 for IV administration or in patients w/ CrCl <45 mL/min or eGFR <60 mL/min/1.73 m2 for intra-arterial administration of iodinated contrast materials, metformin must be discontinued 48 hr before the test. More frequent blood glucose monitoring may be required, especially at the beginning of treatment w/ medicinal products w/ intrinsic hyperglycemic activity [eg, glucocorticoids & tetracosactides (systemic & local routes), β2 agonists, danazol, chlorpromazine at high dose (100 mg/day) & diuretics]. Increased risk of lactic acidosis w/ loop diuretics & in acute alcohol intoxication particularly in case of fasting or malnutrition, hepatic insufficiency. Reduced efficacy w/ OCT1 substrate/inhibitors (eg, verapamil). Increased GI absorption & efficacy w/ OCT1 inducers (eg, rifampicin). Decreased renal elimination & increased plasma conc w/ OCT2 substrates/inhibitors (eg, cimetidine, dolutegravir, crizotinib, olaparib, daclatasvir, vandetanib).
MIMS Class
ATC Classification
A10BA02 - metformin ; Belongs to the class of biguanides. Used in the treatment of diabetes.
Presentation/Packing
Form
Glucophage Forte tab 850 mg
Packing/Price
120's
Form
Glucophage tab 1 g
Packing/Price
60's
Form
Glucophage tab 500 mg
Packing/Price
100's
Form
Glucophage XR tab 1 g
Packing/Price
60's
Form
Glucophage XR tab 500 mg
Packing/Price
30's
Form
Glucophage XR tab 750 mg
Packing/Price
60's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in